|
|
Press Releases [2010]
UNIVERSITY OF MARYLAND SCHOOL OF NURSING LICENSES GENEGO’S METACORE PLATFORM
St. Joseph, Michigan, January 19th, 2010 – GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the University of Maryland School of Nursing has licensed its pathway analysis and knowledge mining suite MetaCore. The latest version, MetaCore 6.0 includes a new easy to use interface, with unique interactome analysis tools, simple searching of GeneGo’s high quality manually curated content and direct links from the drug detail pages to Sigma Aldrich for purchasing compounds.
“We prefer the coverage and quality of disease annotation, as well as the rodent specific pathway analysis, which is critical to seeing species differences. I am not aware of another platform that has this capability,” said Susan Dorsey, Director, UMB Center for Pain Studies.
“We are always told that we have the broadest and deepest coverage of content in the systems biology pathway area with the highest quality manual curation,” said Julie Bryant, VP of Business Development. “As we focus on building our disease platforms our depth of coverage will continue to grow and provide more levels of granularity for our users on diseases, processes and toxicology.”
GENEGO RECEIVES SBIR GRANT
St. Joseph, MI. January 12th, 2010 – GeneGo, Inc., the leading systems biology tools company, announced today they have been awarded $336K Phase I SBIR grant from the NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES for creating a novel type of predictive signatures for drug resistance. Under this project GeneGo will develop “regulation signatures” which should overcome many shortcomings of existing methods of molecular diagnostics. For this work GeneGo will utilize its extensive, manually-curated database of signaling interactions and recently developed algorithms for identifying key proteins in signaling networks. The work will be performed in collaboration with the Van Andel Institute for Translational Medicine.
“What we propose here is the novel concept of using inferred activity of key signaling proteins for building predictive models. Our early results indicate that such models should be significantly more robust than currently available diagnostic applications which are based directly on gene or protein levels. We are very excited about the opportunity provided by NIH support to further develop and validate this approach. If successful, the methodology could be replicated for developing predictive models for sensitivity to a broad range of targeted therapies, leading to a number of diagnostic applications such as specialized molecular tests, systems for formulating combination therapies and procedures for selecting patient cohorts for clinical trials” said Andrej Bugrim, GeneGo COO and PI on the grant.
GENEGO LAUNCHES EASY ACCESS TO SIGMA ALDRICH PRODUCTS FROM METACORE, METADRUG AND EUREKA!
St. Joseph, MI. January 7th, 2010 –GeneGo, Inc., the leading systems biology tools company, announced today that they have launched easy access to many Sigma Aldrich life science and chemistry products from their “Drug Details” pages in three products: MetaCore 6.0, MetaDrug and Eureka! This new capability allows customers to retrieve comprehensive information on drugs and compounds and make one-click purchases all from one centralized location. Such efficiency tools are crucial to busy bench scientists.
“It’s critical that Sigma Aldrich has a presence through out all stages of an experiment’s life cycle,” said Nathan Allen, Market Segment Manager, Sigma Aldrich. “By incorporating our products into MetaCore, MetaDrug, and Eureka! we ensure that researchers have easy access to Sigma Aldrich products presented in the appropriate context during the initial stages of experiment preparation.”
“We have many mutual customers requesting easy access to product vendors such as Sigma Aldrich, so it was the logical thing to do,” said Julie Bryant, GeneGo’s VP of Business development. “In a typical workflow, our users formulate hypotheses, for instance on a mode of action for a new drug, followed by a set of validation experiments. The new tool allows them to find the necessary compounds for the experiments, cost out a project and make purchases on the relevant Sigma Aldrich landing pages.”
GENEGO TO SELL OMICSOFT PRODUCTS
St. Joseph, MI. January 5th, 2010 – GeneGo, Inc., the leading systems biology tools company, announced today that they will be selling Omicsoft products Array Studio and Array Server globally except for Japan. Array Studio is a software package which provides state of the art statistics and visualization for the analysis of high dimensional quantification data (OMICs data). Array Server is an enterprise data repository solution, allowing users to store, share, search, and integrate their microarray/SNP/CNV projects and data. These tools are seamlessly integrated with GeneGo’s data mining suites MetaCore™ and MetaDrug™ allowing in depth analysis of different types of OMICs data.
“We are very delighted to set up this collaboration with GeneGo Inc. At Omicsoft, we focus on biomarker data management, visualization, and analysis. To achieve this, we design software that is easy enough to be used by the bench scientist, but powerful enough to be used by the bioinformatician or statistician. We have also fully analyzed more than 5,000 public datasets for our users. Interpretation of both public and proprietary datasets requires sophisticated bioinformatics tools such as those from GeneGo. GeneGo’s success in this area is unparalleled, and we hope to contribute to their continued success with this agreement. The collaboration was triggered by the same feature-on-demand philosophy shared by the two companies: improving our solutions based on customer requests. With this partnership, Omicsoft can continue to focus on new technology developments, including next generation sequencing enterprise solutions.”, said Jack Liu, President of Omicsoft. “Interpretation of complex OMICs datasets requires both empirical statistical analysis of large data repositories and “knowledge-based” functional analysis based on manually curated pathways and ontologies. We believe that Omicsoft’s and our products are “best in class” in the corresponding fields, so bundling our solutions makes perfect scientific and commercial sense”, said Julie Bryant, GeneGo’s VP of Business development. “Many of our customers see the value in easy access, search and retrieval of public domain experimental data, followed by functional “pathway” analysis, including ontology enrichment, networks and interactome topology. While working with Omicsoft, we were impressed with their tools and now we look forward to representing them in the field.”
|
